In-vitro Lung Model Market
In-vitro Lung Model Market - Global Industry Assessment & Forecast
#
Pages:
120
2022
Mar - 2023
VMR-1337
Segments Covered
By
Type 2D Cell Models, 3D Cell Models
-
By
Application Drug Screening, Toxicology, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 321.20 Million |
 Revenue 2030:
|
USD 1112.58 Million |
 Revenue CAGR
(2023 - 2030): |
16.80% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: In-vitro Lung Model Market by Type by Application by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 21-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for In-vitro Lung Model in terms of revenue?
-
The global In-vitro Lung Model valued at USD 321.20 Million in 2022 and is expected to reach USD 1112.58 Million in 2030 growing at a CAGR of 16.80%.
Which are the prominent players in the market?
-
The prominent players in the market are Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 16.80% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the In-vitro Lung Model include
- Rising Prevalence of Lung Diseases and Increasing Research on Lung Disorders
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the In-vitro Lung Model in 2022.
